Stock Events

Stock Events

Burning Rock Biotech 

$9.78
12
+$0.53+5.73% Friday 20:00
+$0.00+0%Friday 20:00After hours

Statistics

Day High
9.7
Day Low
9.7
52W High
41.72
52W Low
6.79
Volume
909
Avg. Volume
-
Mkt Cap
103.14M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

29MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-2.35
-1.63
-0.9
-0.18
Expected EPS
N/A
Actual EPS
-1.6

Financials

-10.27%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
75.62MRevenue
-7.77MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BNR. It's not an investment recommendation.
Tesla
4
TSLA
Amazon
4
AMZN
Alphabet
4
GOOG
Microsoft
3
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap21.1B
Guardant Health offers liquid biopsy tests similar to Burning Rock, competing in the cancer detection and treatment market.
Illumina
ILMN
Mkt Cap28.82B
Illumina provides sequencing and array-based solutions for genetic analysis, which are foundational to the services offered by Burning Rock.
Fulgent Genetics
FLGT
Mkt Cap510.68M
Fulgent Genetics offers comprehensive genetic testing, competing in the same space as Burning Rock with a focus on cancer.
Pacific Biosciences of California
PACB
Mkt Cap357.46M
Pacific Biosciences offers sequencing systems that compete with Burning Rock's genomic analysis technologies.
Adaptive Biotechnologies
ADPT
Mkt Cap3.94B
Adaptive Biotechnologies focuses on the immune-driven discovery and development of cancer therapies, indirectly competing with Burning Rock's diagnostic services.
Bionano Genomics
BNGO
Mkt Cap13.9M
Bionano Genomics provides tools for genomic analysis, competing in the broader market of genetic testing and analysis that includes cancer diagnostics.
CRISPR Therapeutics
CRSP
Mkt Cap5.18B
CRISPR Therapeutics is engaged in gene editing, a technology that has implications for cancer treatment and diagnostics, thus competing in a related biotech innovation space.

About

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Show more...
CEO
Yusheng Han
Employees
667
Country
China
ISIN
US12233L2060
WKN
000A40AE6

Listings

STU
DE
6BU0.STU
STU
DE
6BUA.STU
XNAS
US
BNR
F
DE
6BU0.F

0 Comments

Share your thoughts

FAQ

What is Burning Rock Biotech stock price today?▼
The current price of BNR is $9.78 USD — it has increased by +5.73% in the past 24 hours. Watch Burning Rock Biotech stock price performance more closely on the chart.
What is Burning Rock Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Burning Rock Biotech stocks are traded under the ticker BNR.
Is Burning Rock Biotech stock price growing?▼
BNR stock has risen by +10.76% compared to the previous week, the month change is a +9.27% rise, over the last year Burning Rock Biotech has showed a +4.72% increase.
What is Burning Rock Biotech market cap?▼
Today Burning Rock Biotech has the market capitalization of 103.14M
What were Burning Rock Biotech earnings last quarter?▼
BNR earnings for the last quarter are -1.6 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Burning Rock Biotech revenue for the last year?▼
Burning Rock Biotech revenue for the last year amounts to 75.62M USD.
What is Burning Rock Biotech net income for the last year?▼
BNR net income for the last year is -7.77M USD.
How many employees does Burning Rock Biotech have?▼
As of August 23, 2026, the company has 667 employees.
In which sector is Burning Rock Biotech located?▼
Burning Rock Biotech operates in the Health & Wellness sector.
When did Burning Rock Biotech complete a stock split?▼
The last stock split for Burning Rock Biotech was on May 15, 2024 with a ratio of 1:10.
Where is Burning Rock Biotech headquartered?▼
Burning Rock Biotech is headquartered in Guangzhou, China.